Stock Scorecard
Stock Summary for Eton Pharmaceuticals Inc (ETON) - $13.05 as of 12/30/2024 12:57:56 PM EST
Total Score
10 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ETON
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ETON
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ETON
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ETON
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ETON (27 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for ETON
Financial Details for ETON
Company Overview |
|
|---|---|
| Ticker | ETON |
| Company Name | Eton Pharmaceuticals Inc |
| Country | USA |
| Description | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 13.05 |
| Price 4 Years Ago | 8.13 |
| Last Day Price Updated | 12/30/2024 12:57:56 PM EST |
| Last Day Volume | 98,708 |
| Average Daily Volume | 227,771 |
| 52-Week High | 13.98 |
| 52-Week Low | 3.03 |
| Last Price to 52 Week Low | 330.69% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.50 |
| Sector PE | 40.21 |
| 5-Year Average PE | -34.70 |
| Free Cash Flow Ratio | 16.73 |
| Industry Free Cash Flow Ratio | 11.85 |
| Sector Free Cash Flow Ratio | 27.17 |
| Current Ratio Most Recent Quarter | 1.51 |
| Total Cash Per Share | 0.78 |
| Book Value Per Share Most Recent Quarter | 0.52 |
| Price to Book Ratio | 20.64 |
| Industry Price to Book Ratio | 4.95 |
| Sector Price to Book Ratio | 20.56 |
| Price to Sales Ratio Twelve Trailing Months | 11.27 |
| Industry Price to Sales Ratio Twelve Trailing Months | 81.76 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.58 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 25,836,200 |
| Market Capitalization | 337,162,410 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -12.60% |
| Annual Earnings Growth | 89.62% |
| Reported EPS 12 Trailing Months | -0.26 |
| Reported EPS Past Year | -0.13 |
| Reported EPS Prior Year | -0.06 |
| Net Income Twelve Trailing Months | -5,481,000 |
| Net Income Past Year | -936,000 |
| Net Income Prior Year | -9,021,000 |
| Quarterly Revenue Growth YOY | -24.40% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -32.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 20,261,000 |
| Total Cash Past Year | 21,388,000 |
| Total Cash Prior Year | 16,305,000 |
| Net Cash Position Most Recent Quarter | 16,136,000 |
| Net Cash Position Past Year | 21,388,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 5,384,000 |
| Total Debt Most Recent Quarter | 4,125,000 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.79 |
| Total Stockholder Equity Past Year | 15,477,000 |
| Total Stockholder Equity Prior Year | 13,078,000 |
| Total Stockholder Equity Most Recent Quarter | 15,981,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -536,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.02 |
| Free Cash Flow Past Year | 6,040,000 |
| Free Cash Flow Prior Year | 2,033,000 |
Options |
|
| Put/Call Ratio | 0.65 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.55 |
| MACD Signal | 0.69 |
| 20-Day Bollinger Lower Band | 2.01 |
| 20-Day Bollinger Middle Band | 8.45 |
| 20-Day Bollinger Upper Band | 14.90 |
| Beta | 1.26 |
| RSI | 59.22 |
| 50-Day SMA | 5.47 |
| 150-Day SMA | 4.13 |
| 200-Day SMA | 4.55 |
System |
|
| Modified | 12/27/2024 11:49:21 PM EST |